Co-Authors
This is a "connection" page, showing publications co-authored by Carolanne Milligan and Michael Cartwright.
Connection Strength
0.698
-
Wosiski-Kuhn M, Caress JB, Cartwright MS, Hawkins GA, Milligan C. Interleukin 6 (IL6) level is a biomarker for functional disease progression within IL6R358Ala variant groups in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener. 2021 05; 22(3-4):248-259.
Score: 0.187
-
Wosiski-Kuhn M, Robinson M, Strupe J, Arounleut P, Martin M, Caress J, Cartwright M, Bowser R, Cudkowicz M, Langefeld C, Hawkins GA, Milligan C. IL6 receptor358Ala variant and trans-signaling are disease modifiers in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm. 2019 11; 6(6):e631.
Score: 0.176
-
Qadri S, Langefeld CD, Milligan C, Caress JB, Cartwright MS. Racial differences in intervention rates in individuals with ALS: A case-control study. Neurology. 2019 04 23; 92(17):e1969-e1974.
Score: 0.169
-
Pathak S, Caress JB, Wosiski-Kuhn M, Milligan C, Williams D, Cartwright MS. A pilot study of neuromuscular ultrasound as a biomarker for amyotrophic lateral sclerosis. Muscle Nerve. 2019 02; 59(2):181-186.
Score: 0.166